摘要
急性冠状动脉综合征发作后6个月内心肌梗死和死亡风险的预测：前瞻性、多国家观察研究（GRACE）,一项20536例患者随机试验中不同风险组及不同年龄组中辛伐他汀的终生成本效益分析,围手术期应用他汀类药物治疗减少心血管风险的证据的强度：多项对照研究的系统回顾,
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome： Prospective multinational observational study（GRACE）,Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from randomised trial of 20 536 people,Strength of evidence for perioperative use of statins to reduce cardiovascular risk： Systematic review of controlled studies,
